ICUI - Company ID 0000883984
The table below shows ICU MEDICAL INC/DE's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $530.23M | $536.99M | $548.87M | $604.70M | $589.13M | $596.46M |
| Cost of revenue | $324.00M | $336.11M | $340.80M | $394.59M | $384.28M | $389.03M |
| Gross profit | $206.23M | $200.88M | $208.06M | $210.11M | $204.85M | $207.43M |
| R&D | $21.28M | $21.25M | $21.87M | $23.29M | $21.03M | $23.39M |
ICU MEDICAL INC/DE reported annual revenue of $2.23B for fiscal year 2025. That is down 6.3% from $2.38B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $379.37M (FY 2016) to $2.23B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $154.57M | $152.77M | $159.39M | $157.23M | $162.71M | $159.55M |
| Operating income | $13.58M | $13.72M | $10.59M | $12.89M | $8.24M | $7.69M |
| Income tax | -$34.71M | -$658.00K | $1.18M | $4.57M | $15.05M | $1.87M |
| Net income | $30.13M | -$3.40M | $35.34M | -$15.48M | -$32.98M | -$21.41M |
| EPS (diluted) | $1.20 | -$0.14 | $1.43 | -$0.63 | -$1.35 | -$0.88 |